ABIVAX news, videos and press releases
For more news please use our advanced search feature.
ABIVAX - More news...
ABIVAX - More news...
- EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
- Abivax publishes financial reports with the French and U.S. securities regulatory agencies
- EQS-News: Abivax Announces Full Year 2024 Financial Results
- Abivax Announces Full Year 2024 Financial Results
- EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
- Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
- EQS-News: Abivax Publishes 2025 Financial Calendar
- Abivax Publishes 2025 Financial Calendar
- EQS-News: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
- Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
- EQS-News: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
- Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
- EQS-News: Abivax Announces a Change to the Composition of its Board of Directors
- Abivax Announces a Change to the Composition of its Board of Directors
- EQS-News: Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
- Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
- EQS-News: Abivax presents third quarter 2024 key financial information
- Abivax presents third quarter 2024 key financial information
- EQS-News: Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
- Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
- ABIVAX Announces Termination of Liquidity Contract and Publishes End of Contract Statement.
- EQS-News: Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
- Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
- EQS-News: Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
- Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
- Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
- EQS-News: Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
- EQS-News: Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
- Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
- EQS-News: Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model
